{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:22:26Z","timestamp":1792030946782,"version":"4.4.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jama.2020.19224","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T17:48:52Z","timestamp":1606844932000},"page":"2211","source":"Crossref","is-referenced-by-count":40,"title":["Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018"],"prefix":"10.1001","volume":"324","author":[{"given":"Jenna","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Murray Horwitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Bertisch","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana J.","family":"Herzig","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Buysse","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"jld200103r1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.sleep.2014.12.008","article-title":"Trends in insomnia and excessive daytime sleepiness among US adults from 2002 to 2012.","volume":"16","author":"Ford","year":"2015","journal-title":"Sleep Med"},{"issue":"2","key":"jld200103r2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5665\/sleep.3410","article-title":"National use of prescription medications for insomnia: NHANES 1999-2010.","volume":"37","author":"Bertisch","year":"2014","journal-title":"Sleep"},{"issue":"3","key":"jld200103r3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/sleep\/22.3.371","article-title":"Ten-year trends in the pharmacological treatment of insomnia.","volume":"22","author":"Walsh","year":"1999","journal-title":"Sleep"},{"issue":"2","key":"jld200103r4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline.","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"jld200103r5","unstructured":"US Food and Drug Administration. FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. Published May 14, 2013. Accessed June 30, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-approves-new-label-changes-and-dosing-zolpidem-products-and"},{"key":"jld200103r6","unstructured":"US Food and Drug Administration. FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines: FDA drug safety communication. Published April 30, 2019. Accessed June 30, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2773553\/jama_wong_2020_ld_200103_1606767629.07975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T17:49:31Z","timestamp":1606844971000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2773553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":6,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.19224","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}